Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern pharmaceutical production that meets international GMP standards. Rafarma Pharmaceuticals has consolidated and is in the process of consolidating…
Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings with the City Scientific University of Istanbul (Turkey) (https://cerrahpasa.istanbulc.edu.tr) to establish a nuclear medicine and proton therapy center at the university.…
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021, the company entered negotiations and formed an action plan with the Matam Technopark in Haifa, Israel (https://www.gav-yam.co.il/en/projects/gav-yam-haifa-bay) to pursue joint development,…
Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given Rafarma’s current market position and the regulatory arena for the circulation of medicinal drugs in…
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development Agency of Uzbekistan which is essentially the Health Department of Uzbekistan. Together the two…
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the previously-announced Biocogency merger, Bebig LLC (http://en.bebig.ru), received an updated Russian registration certificate for the production and…
Nicosia, Cyprus, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia. Under the terms of the agreement, Rafarma and Vaccines Lab with creating a new jointly-operated vaccine facility…
Nicosia, Cyprus, Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov: “It is my pleasure to provide the following update on Rafarma’s exciting future that should…
Nicosia, Cyprus, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that the elite Chicago auditing firm LJ Soldinger Associates (https://www.soldinger.com/) has been retained to provide auditing services for the resulting Rafarma group of companies from the Biocogency/Rafarma…
Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated financials will include Slavich (http://www.slavich.ru), Slavich Trading House, and related companies based in Spain, Ireland,…
Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the approval of Ilya Shpurov receiving the majority of Preferred B shares, conferring voting control of the company, toward the combination of its acquisition by R.…
Ljubljana, Slovenia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the appointment of Ilia Shpurov as Chairman of the Board. Mr. Shpurov has a long history of technological developments, patents, and entrepreneurial achievements in biotech. Most…
Ljubljana, Slovenia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that Mr. Anucha Pehtpeng, Rafarma’s Director of Thai Operations, represented the company along with leading research teams from Mahidol University, Yala University, and Siriraj Hospital. at a…
Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is registered under the name of RAFARMA (THAILAND) CO., LTD. The Company…
Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY LABORATORIES Group of Companies (“Biocogency”) of Cyprus. As per the…
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our Shareholders: During these exciting times I wanted to reach out to our shareholders and clarify…
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd (“Biocogency”). Under the agreed terms, Bio-cogency will…
Ljubljana, Slovenia, June 22, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce the finalization of the agreement with Destination Marketing Group Co. Ltd. Thailand. Under the agreement, Destination Marketing will provide outsourcing services for the production of CBD-infused…
Ljubljana, Slovenia, June 15, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, (OTC:(RAFA) Inc. is happy to announce commencement of tests for its new product “HempySleep”. The product was designed by the company to fight increasing problems of insomnia around the world. Insomnia-curing…
Sevnica, Slovenia, May 28, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is excited to announce the commencement of its production of cannabis-based wine, also known as “Green Wine,” on its Mastnak Winery fields in Slovenia. The production will…
Ljubljana, Slovenia, April 16, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. is pleased to announce acquisition of all outstanding US and Australian patents from Vladislav Laskavy, PhD. The patents that the company has acquired will give the…
Ljubljana, Slovenia, April 06, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - In establishing its Advisory Board, Rafarma Pharmaceuticals announces the appointment of its first board member, Vladislav N. Laskavy, PhD., who will begin advising the company and assisting with the…
Ljubljana, Slovenia, March 23, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. is pleased to announce that it has successfully completed negotiations with Albopark Ocio SL (a New Heled Spain Holding company), which is the owner of the…
Ljubljana, Slovenia, March 06, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Dear Shareholders: Since a recent teleconference call was held with shareholders there have been many things that have taken place. I would like to address some of the exciting…
Ljubljana, Slovenia, Feb. 24, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” is pleased to inform its shareholders that the previously-announced specialized research project between Rafarma and Khon Kaen University officially commenced on February 19, 2020. In a meeting at the University,…
Ljubljana, Slovenia, Feb. 10, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma is moving forward with its research initiatives for medicinal cannabis in Thailand. The research programs initiated by Rafarma will be focused mainly on developing precise protocols for treatment…
Ljubljana, Slovenia, Jan. 27, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Following on the recently-announced partnership between Rafarma Pharmaceuticals, Inc. and Thailand’s MTP Material Co. Ltd., Rafarma is pleased to announce the commencement of its Specialized Detox Centers project…
Ljubljana, Slovenia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL CO. LTD. (“MTP”). This marks the first time a U.S. company has entered…
Ljubljana, Slovenia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”. Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai operations, Mr. Anucha Phetpheng. Mr. Phetpheng, 55, resides both in Bangkok and Phuket, Thailand with…
Ljubljana, Slovenia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma Pharmaceuticals, Inc. announces that following meetings this past week in Bangkok and Khon Kaen, Thailand, it has signed a Letter of Intent to acquire a 49% interest in…
Ljubljana, Slovenia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. announces the cancellation of all outstanding Preferred Class A shares. On August 28th, 2019, The company’s Board of Directors unanimously voted to cancel the 30,000,000 previously-issued…
Ljubljana, Slovenia, Aug. 23, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is positioning to expand its operations in the “next big thing” in cannabis production—Thailand. Rafarma is currently in talks with Thai partners to open cannabis farms and specialized…
Ljubljana, Slovenia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite the adverse weather conditions in the 2019 growing season, the quality of the company's harvested…
Ljubljana, Slovenia, July 12, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo Bojt shall remain as a company Director. Vladimir G. Dolgolenko, who resides…
Ljubljana, Slovenia, July 08, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of Thailand to use the company’s proprietary blockchain software developed by Aetsoft to manage…
Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the leading developers of blockchain software in the world (https://www.aetsoft.by/en/). Under the…
Ljubljana, Slovenia, June 07, 2019 (GLOBE NEWSWIRE) -- Rafarma (RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition agreement with Dr. Yury Martirosian of Russian Academy of Scientists. Under the agreement, Rafarma is…
Ljubljana, Slovenia, May 31, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”, a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis in Slovenia through its wholly-owned subsidiary (Green Drop D.O.O.). The Application was one of…
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Ljubljana, Slovenia , May 30, 2019 (GLOBE NEWSWIRE) -- Rafarma (RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its spokesperson and new face of the company. The pairing launches a joint…